848
Participants
Start Date
December 31, 2002
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
Ramelteon
Ramelteon, 8 mg, tablets, orally, once daily for up to 5 weeks.
Ramelteon
Ramelteon, 16 mg, tablets, orally, once daily for up to 5 weeks.
Placebo
Ramelteon placebo-matching tablets, orally, once daily for up to 5 weeks.
Birmingham
Mobile
Mesa
Phoenix
Scottsdale
Tempe
Hot Springs
Little Rock
Anaheim
Chula Vista
Irvine
La Mesa
Newport Beach
Northridge
Oakland
Redlands
Spring Valley
Colorado Springs
Denver
Clearwater
Hollywood
Jacksonville
Longwood
Pembroke Pines
Safety Harbor
St. Petersburg
Tampa
Vero Beach
West Palm Beach
Winter Park
Atlanta
Blairsville
Decatur
Macon
Marietta
Arlington Heights
Chicago
Danville
Evansville
Shawnee Mission
Bethesda
Brockton
Detroit
Hattiesburg
St Louis
Lawrenceville
Moorestown
Albuquerque
Mineola
Williamsville
Cary
Raleigh
Winston-Salem
Beachwood
Cincinnati
Oklahoma City
Altoona
Jenkintown
Philadelphia
Sellersville
Warwick
Mt. Pleasant
Johnson City
Dallas
Houston
San Antonio
Salt Lake City
Norfolk
Virginia Beach
Gig Harbor
Lead Sponsor
Takeda
INDUSTRY